Prelude Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $291K | Buy |
|
|||||
|
2024
Q2 | $292K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $295K | Buy |
|
|||||
|
2023
Q3 | $216K | Sell |
|
|||||
|
2023
Q2 | $253K | Sell |
|
|||||
|
2023
Q1 | $302K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $185K | Buy |
|
|||||
|
2021
Q1 | – | Hold |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $246K | Sell |
|
|||||
|
2020
Q2 | $365K | Sell |
|
|||||
|
2020
Q1 | $426K | Buy |
|
|||||
|
2019
Q4 | $335K | Buy |
|
|||||
|
2019
Q3 | $232K | Buy |
|
|||||
|
2019
Q2 | $165K | Sell |
|
|||||
|
2019
Q1 | $169K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $9K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $8K | Buy |
|
|||||
|
2017
Q2 | $0 | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1K | Buy |
|
|||||
|
2015
Q2 | – | Hold |
|
|||||
|
2015
Q1 | – | Hold |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $3K | Sell |
|
|||||
|
2014
Q2 | $47K | Sell |
|
|||||
|
2014
Q1 | $149K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $25K | Buy |
|